Medicare Enrolled
Dr. Robert Ferdman, M.D.
Medical Oncology · Fleming Island, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ferdman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferdman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ferdman
Dr. Robert Ferdman is a medical oncology specialist in Fleming Island, FL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Ferdman performed 16,525 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ferdman received a total of $4,244 from 46 pharmaceutical and/or device companies across 200 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ferdman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 42% volume in FL
$4,244 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 157835 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗16,525
Medicare services
Top 42% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
12,240 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
490 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
303 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
279 | $8 | $29 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
136 | $49 | $189 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
124 | $22 | $84 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
124 | $99 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
115 | $11 | $69 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
106 | $16 | $56 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $70 | $239 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
71 | $81 | $298 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
62 | $98 | $378 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $120 | $453 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
30 | $12 | $61 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $129 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
76.7% high complexity
17.6% medium
5.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,244
Total received (2022-2024)
Avg $1,415/year across 3 years
Bottom 41% in FL for medical oncology
46
Companies
200
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,946
2023
$1,273
2022
$25
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$296
Novartis Pharmaceuticals Corporation
$256
Janssen Biotech, Inc.
$247
PFIZER INC.
$224
Celgene Corporation
$169
Bayer Healthcare Pharmaceuticals Inc.
$115
GENZYME CORPORATION
$112
Lilly USA, LLC
$108
Takeda Pharmaceuticals U.S.A., Inc.
$106
Merck Sharp & Dohme LLC
$103
Eisai Inc.
$87
Daiichi Sankyo Inc.
$85
Kite Pharma, Inc.
$82
TerSera Therapeutics LLC
$79
E.R. Squibb & Sons, L.L.C.
$76
Exelixis Inc.
$72
Gilead Sciences, Inc.
$68
Stemline Therapeutics Inc.
$68
Regeneron Healthcare Solutions, Inc.
$61
Alexion Pharmaceuticals, Inc.
$53
ABBVIE INC.
$51
BeiGene USA, Inc.
$50
GlaxoSmithKline, LLC.
$47
Ipsen Biopharmaceuticals, Inc
$46
SERVIER PHARMACEUTICALS LLC
$43
TAIHO ONCOLOGY, INC.
$37
Astellas Pharma US Inc
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Aveo Pharmaceuticals, Inc.
$19
Karyopharm Therapeutics Inc.
$18
ARRAY BIOPHARMA INC
$18
SpringWorks Therapeutics, Inc.
$18
Genentech USA, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$17
Pharmacosmos Therapeutics Inc.
$16
Sumitomo Pharma America, Inc.
$15
Top 3 companies account for 27.2% of 2024 payments
All-time payments by company (2022-2024) ›
AstraZeneca Pharmaceuticals LP
$359
Novartis Pharmaceuticals Corporation
$347
PFIZER INC.
$324
Janssen Biotech, Inc.
$286
Merck Sharp & Dohme LLC
$264
Celgene Corporation
$231
Gilead Sciences, Inc.
$157
Bayer Healthcare Pharmaceuticals Inc.
$129
GENZYME CORPORATION
$129
E.R. Squibb & Sons, L.L.C.
$111
Kite Pharma, Inc.
$110
Eisai Inc.
$109
Alexion Pharmaceuticals, Inc.
$108
Lilly USA, LLC
$108
Seagen Inc.
$107
Takeda Pharmaceuticals U.S.A., Inc.
$106
Astellas Pharma US Inc
$98
TerSera Therapeutics LLC
$96
Daiichi Sankyo Inc.
$85
Exelixis Inc.
$72
TAIHO ONCOLOGY, INC.
$72
ABBVIE INC.
$69
Stemline Therapeutics Inc.
$68
GlaxoSmithKline, LLC.
$66
Regeneron Healthcare Solutions, Inc.
$61
Genentech USA, Inc.
$51
BeiGene USA, Inc.
$50
Ipsen Biopharmaceuticals, Inc
$46
Sumitomo Pharma America, Inc.
$45
Progenics Pharmaceuticals, Inc.
$45
SERVIER PHARMACEUTICALS LLC
$43
G1 Therapeutics, Inc.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Novocure Inc.
$22
Amgen Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
Karyopharm Therapeutics Inc.
$18
ARRAY BIOPHARMA INC
$18
Mirati Therapeutics, Inc.
$18
SpringWorks Therapeutics, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$17
Puma Biotechnology, Inc.
$16
Pharmacosmos Therapeutics Inc.
$16
Jazz Pharmaceuticals Inc.
$16
Adaptive Biotechnologies Corporation
$13
Deciphera Pharmaceuticals Inc.
$13
Top 3 companies account for 24.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · DARZALEX · ELAHERE · ELREXFIO · ENHERTU · ENJAYMO · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · IBRANCE · IMFINZI · INLYTA · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONOFERRIC · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PLUVICTO · PYLARIFY · Padcev · Polivy · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · SARCLISA · SCEMBLIX · SHINGRIX · Stivarga · TECVAYLI · TIVDAK · TUKYSA · Tibsovo · ULTOMIRIS · VENCLEXTA · VERZENIO · XALKORI · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
13
County median income
$86,094
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA ORANGE PARK HOSPITAL
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ferdman is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ferdman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ferdman performed 12,240 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ferdman receive payments from pharmaceutical companies?
Yes. Dr. Ferdman received a total of $4,244 from 46 companies across 200 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ferdman's costs compare to other medical oncologists in Fleming Island?
Dr. Ferdman's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ferdman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fleming Island
Browse medical oncologists in Fleming Island ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology